ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes
M. Loredana Marcovecchio(University of Cambridge), David B. Dunger(Addenbrooke's Hospital), John Deanfield(Universidad de Londres), Simon Bond(Cambridge University Hospitals NHS Foundation Trust), Farid H. Mahmud(SickKids Foundation), Scott T. Chiesa(Czech Academy of Sciences, Institute of Experimental Medicine), Kim C. Donaghue(The University of Sydney), Sally M. Marshall(Cambridge University Hospitals NHS Foundation Trust), Sarah Dawson(Papworth Hospital NHS Foundation Trust), R. Neil Dalton(Evelina London Children's Healthcare), Timothy W. Jones(The University of Western Australia), H. A. W. Neil(University of Ulster), Denis Daneman(Hospital for Sick Children)
Cited by 111
Related Papers
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
|The Lancet|1992|4.8k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k